Newman Michael James's Form 4 filing
Indaptus Therapeutics, Inc. (INDP) · filed Feb 2, 2022
- Accession no.
- 0001493152-22-003002
- Filed
- Feb 2, 2022
- Trade date
- Jan 31-Feb 1, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $100.0K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Newman Michael JamesCIK 0001876315 | Director, Officer (CSO and Director), 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 31, 2022 | Common Stock | SSaleDisposed | −5,870 | $5.00 | −$29,350 | 1,382,486 | Indirect | |
| Feb 1, 2022 | Common Stock | SSaleDisposed | −14,130 | $5.00 | −$70,650 | 1,368,356 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.